Position in ENLV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$128,644
+$104,048 QoQ
Shares Held
138,328
+295.4% QoQ
Ownership
0.822%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ENLV ranks #352 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ENLV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $128,644 | 138,328 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $24,596 | 34,988 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,201 | 4,040 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $15 | 16 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18 | 16 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,403 | 3,217 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22 | 16 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,631 | 3,069 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,890 | 3,663 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,090 | 690 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $46,785 | 17,810 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $114,488 | 31,453 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $131,705 | 33,445 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $135,451 | 31,871 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $83,081 | 18,381 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $98,847 | 17,683 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135,286 | 21,646 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $152,684 | 15,454 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $119,438 | 13,420 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $120,569 | 10,872 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $188,823 | 22,399 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $60,766 | 10,230 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,740 | 344 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||